Greenlight Capital Re Ltd
10 nominees · 3 ballot items.
Election of ten directors to the board, ratification of Deloitte as independent auditors for 2025, and a non-binding advisory vote on executive compensation.
Follow how the vote landed and what changed on Greenlight Capital Re Ltd’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot3
- 1
Election of Directors
ManagementBoard: FORElection of ten directors to serve on the Board until the Annual General Meeting of Shareholders in 2026.
- 2
Ratification of Appointment of the Company’s Auditors
ManagementBoard: FORRatify the appointment of Deloitte Ltd. to serve as the independent auditors of the Company for the 2025 fiscal year.
- 3
Advisory Vote on Executive Compensation
ManagementBoard: FORNon-binding advisory vote on the compensation of the Named Executive Officers as disclosed in the Proxy Statement.
Nominees on the ballot10
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | DIMENSIONAL FUND ADVISORS LP | 5.0% | 1,643,663 | $28M |
| 2 | PRIVATE MANAGEMENT GROUP INC | 4.5% | 1,488,181 | $26M |
| 3 | MORGAN STANLEY | 4.0% | 1,318,307 | $23M |
| 4 | CWA Asset Management Group, LLC | 3.5% | 1,158,055 | $20M |
| 5 | BlackRock, Inc. | 3.0% | 996,371 | $17M |
| 6 | BlackRock, Inc. | 2.9% | 966,237 | $17M |
| 7 | AMERIPRISE FINANCIAL INC | 2.0% | 652,678 | $11M |
| 8 | STATE STREET CORP | 1.8% | 596,163 | $10M |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 1.6% | 538,376 | $9M |
| 10 | AMERICAN CENTURY COMPANIES INC | 1.3% | 441,789 | $8M |
Other Financial Services sector meetings6
Upcoming shareholder meetings at Greenlight Capital Re Ltd’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Greenlight Capital Re Ltd 2025 annual meeting?
- Greenlight Capital Re Ltd (GLRE) holds its 2025 annual shareholder meeting on Tuesday, July 29, 2025.
- What is the record date for the Greenlight Capital Re Ltd 2025 meeting?
- The record date for the Greenlight Capital Re Ltd 2025 meeting is Thursday, May 1, 2025. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Greenlight Capital Re Ltd's 2025 meeting?
- The board is presenting 10 director nominees at the Greenlight Capital Re Ltd 2025 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Greenlight Capital Re Ltd 2025 meeting?
- Shareholders will vote on 3 proposals at the Greenlight Capital Re Ltd 2025 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.